EUVIMEDEUVIMED entdecken
Crossref

Immunopathology and therapeutic strategies for long COVID: mechanisms, manifestations, and clinical implications

Enaam M Junainah, Azza H Abd-El-Rahman, Amin A Alamin, Khalid E Hassan, Basem H Elesawy, Ahmed H Elrashidy, Amal A Alhosary, Hammad Tufail-Chaudhary, Ayman E El-Kenawy, Amna F Bashir, Ghaliah Obaid-Alnefaie, Dalal M Nemenqani und 5 weitere

Aids Reviews · 2025

DOI: 10.24875/aidsrev.24000018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aids Reviews, 2025. Verfasst von Enaam M Junainah und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine, Taif University, Taif, Saudi Arabia. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long coronavirus disease-19 (COVID-19) is a complex, multifactorial condition characterized by persistent symptoms lasting more than 12 weeks following acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The underlying mechanisms remain incompletely understood, but chronic inflammation, immune dysregulation, autoimmunity, and viral persistence are increasingly being implicated. This study investigated the immunopathological drivers of long COVID-19 and their associations with clinical manifestations and organ damage. A prospective, longitudinal cohort study was conducted on 200 COVID-19 survivors aged 18-65 years, in which immune markers, autoantibody profiles, lymphocyte dysfunction, and imaging findings were assessed over a 12-month period. Persistent inflammation was observed, with elevated interleukin-6 and tumor necrosis factor α ± levels correlated with lung fibrosis and cognitive impairment. Autoantibodies were detected in 40% of the participants, particularly those with cardiovascular and neurological symptoms. A significant reduction in CD8+ T-cell counts was associated with severe fatigue and cognitive dysfunction, whereas persistent SARS-CoV-2 RNA was identified in 10% of cases, primarily in individuals with gastrointestinal symptoms. Imaging studies revealed multiorgan involvement, with structural abnormalities in the lungs, heart, and brain. These findings highlight the interplay of immune dysfunction, chronic inflammation, and autoimmunity in long-term COVID-19, underscoring the need for targeted therapeutic strategies to address its long-term health impacts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansMiddle AgedAdultMaleSARS-CoV-2Longitudinal StudiesAgedFemaleProspective StudiesPost-Acute COVID-19 SyndromeAdolescentYoung AdultAutoantibodiesInflammationInterleukin-6

Stichwörter der Autor:innen

AutoimmunityCD8+ T-cell dysfunctionChronic inflammationCytokines interleukin-6Long coronavirus disease-19Tumor necrosis factor-α

Substanzen

AutoantibodiesInterleukin-6

Autor:innen und Institutionen

  • Department of Pathology, College of Medicine, Taif University, Taif, Saudi Arabia.
  • Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Department of Pathology, Faculty of Medicine, Al-Azhar University, Assiut, Egypt.
  • Department of Clinical Pathology, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
  • Department of Pathology, Assiut University, Assiut, Egypt.
  • Department of Microbiology, Taif University, Taif, Saudi Arabia.

Zitieren

APA

Junainah, E. M., Abd-El-Rahman, A. H., Alamin, A. A., Hassan, K. E., Elesawy, B. H., Elrashidy, A. H., Alhosary, A. A., Tufail-Chaudhary, H., El-Kenawy, A. E., Bashir, A. F., Obaid-Alnefaie, G., Nemenqani, D. M., El-Nashar, N. A., Khairy, M., Al-Thobaiti, N. A., Alfahmi, F. K., & Taha, S. A. (2025). Immunopathology and therapeutic strategies for long COVID: mechanisms, manifestations, and clinical implications. Aids Reviews. https://doi.org/10.24875/aidsrev.24000018

Vancouver

Junainah EM, Abd-El-Rahman AH, Alamin AA, Hassan KE, Elesawy BH, Elrashidy AH, et al. Immunopathology and therapeutic strategies for long COVID: mechanisms, manifestations, and clinical implications. Aids Reviews. 2025. doi:10.24875/aidsrev.24000018

BibTeX
@article{Junainah2025,
  author = {Junainah, Enaam M and Abd-El-Rahman, Azza H and Alamin, Amin A and Hassan, Khalid E and Elesawy, Basem H and Elrashidy, Ahmed H and Alhosary, Amal A and Tufail-Chaudhary, Hammad and El-Kenawy, Ayman E and Bashir, Amna F and Obaid-Alnefaie, Ghaliah and Nemenqani, Dalal M and El-Nashar, Nihad A and Khairy, Mostafa and Al-Thobaiti, Nawaf A and Alfahmi, Fawaz K and Taha, Sama A},
  title = {Immunopathology and therapeutic strategies for long COVID: mechanisms, manifestations, and clinical implications},
  journal = {Aids Reviews},
  year = {2025},
  doi = {10.24875/aidsrev.24000018}
}
Kostenlos starten →